Isoform-specific Regulation of the Coxsackie and Adenovirus Receptor in Polarized Epithelia
极化上皮细胞中柯萨奇和腺病毒受体的亚型特异性调节
基本信息
- 批准号:8879657
- 负责人:
- 金额:$ 44.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-22 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdenovirus InfectionsAdenovirusesAdhesionsAffectAirAlternative SplicingApicalBAIAP1 geneBindingCAR receptorCellsCellular biologyCessation of lifeCoxsackie B VirusesCoxsackie VirusesCoxsackievirus InfectionsDataDegradation PathwayDisease OutbreaksDown-RegulationEndoplasmic ReticulumEnvironmentEpithelialEpithelial CellsEpitheliumExonsFamilyGoalsHealthHumanInfectionInheritedInnovative TherapyKnowledgeLeadLipidsLocationLungLung diseasesMalignant NeoplasmsMediatingMedicineMethodologyMicrobeMilitary PersonnelMolecularMolecular VirologyPathogenesisPathway interactionsPeptidesPredispositionPreventionProductivityProtein IsoformsProteinsQuality ControlRNA SplicingRegulationResearchScaffolding ProteinSideSorting - Cell MovementSterilityStructureSurfaceTechniquesTestingTherapeuticTherapeutic IndexTherapeutic InterventionTight JunctionsTonsilTrainingUniversitiesVaccinationViralViral PathogenesisViral PneumoniaViral VectorVirusVirus DiseasesVirus ReceptorsWorkadenoviral-mediatedadenovirus receptorairway epitheliumapical membranebasebasolateral membraneclinically significantcollegegene therapygene therapy clinical trialglycosylationgraduate studenthuman diseaseimprovedinsightinterstitialmathematical sciencesmembermembrane-associated guanylate kinasemicrobialmimeticsnovelpathogenpreventprotein degradationprotein expressionpublic health relevancereceptorreceptor expressiontraffickingundergraduate studentvirology
项目摘要
DESCRIPTION (provided by applicant): Adenovirus is a common human pathogen that was first identified from tonsils in 1953. Over the past 6 decades, adenovirus research has yielded impressive knowledge about the pathogenesis of viral pneumonias, vaccination, and basic aspects of molecular virology and cellular biology. However, adenovirus remains a significant civilian and military threat since no specific therapeutic treatment for adenoviral infection exist. Adenovirus is also clinically significant because it is the most common viral vector used in human gene therapy clinical trials. New techniques that enhance adenovirus infection would, thus, improve the therapeutic index of these innovative therapies. Most adenoviruses and group B coxsackieviruses share a common receptor: coxsackievirus and adenovirus receptor (CAR). A major unanswered question has been how these pathogenic viruses initiate infection from the air-exposed lung epithelial surface. Our group has recently discovered that one of the two transmembrane isoforms of CAR (CAREx8) can localize at the air-exposed apical epithelial surface. Moreover, we have found that a cellular scaffolding protein, membrane-associated guanylate kinase with inverted domain structure 1 (MAGI-1), serves as a master negative regulator for cellular CAREx8 protein expression levels and apical adenovirus entry. Understanding the mechanism by which MAGI-1 regulates CAREx8 may lead to novel and specific therapeutics able to alter the susceptibility of an epithelium to adenovirus infection. We
hypothesize that MAGI-1 downregulates CAREx8 protein expression by marking CAREx8 as a substrate for the protein-surveillance endoplasmic reticulum associated-degradation (ERAD) pathway. We further hypothesize that molecules that block the MAGI-1-CAREx8 interaction will directly affect the susceptibility of an epithelium to adenovirus infection. We aim to understand the molecular basis of MAGI- 1-mediated CAREx8 down regulation and whether specific cell-permeable peptides can interrupt this interaction to either decrease or increase apical adenovirus infection in polarized epithelia. Understanding these molecular mechanisms is clinically significant for several reasons. Currently there is no specific treatment for coxsackievirus or adenovirus infection; thus, the ability to block virus binding in the face of virl outbreaks would be a significant therapeutic advance. On the other hand, the ability to augment apical expression of the receptor would have high relevance for efficient adenoviral-mediated gene therapy for lung diseases, such as cancer. Finally, this work will expose a team of graduate and undergraduate students to vital research at the interface of virology and medicine.
描述(由申请人提供):腺病毒是一种常见的人类病原体,于 1953 年首次从扁桃体中被发现。在过去 6 年来,腺病毒研究已经获得了有关令人印象深刻的病毒性肺炎的发病机制、疫苗接种以及分子病毒学和免疫学基础方面的知识。然而,腺病毒仍然是一个重大的民用和军事威胁,因为腺病毒感染还没有具体的治疗方法,因为它是最常见的病毒载体。因此,增强腺病毒感染的新技术将提高这些创新疗法的治疗指数。大多数腺病毒和 B 族柯萨奇病毒具有共同的受体:柯萨奇病毒和腺病毒受体(CAR)。这些致病病毒如何从暴露于空气的肺上皮表面引发感染,我们的小组最近发现 CAR 的两种跨膜亚型之一(CAREx8)可以。此外,我们发现一种细胞支架蛋白,即具有反向域结构 1 (MAGI-1) 的膜相关鸟苷酸激酶,可作为细胞 CAREx8 蛋白表达水平的主要负调节因子。了解 MAGI-1 调节 CAREx8 的机制可能会产生能够改变上皮对腺病毒感染的易感性的新型特异性疗法。我们
随后,MAGI-1 通过将 CAREx8 标记为蛋白质监视内质网相关降解 (ERAD) 途径的底物来下调 CAREx8 蛋白表达,我们进一步发现阻断 MAGI-1-CAREx8 相互作用的分子将直接影响 CAREx8 的敏感性。我们的目的是了解 MAGI-1 介导的 CAREx8 下调的分子基础以及是否具有特定的细胞渗透性。由于多种原因,肽可以阻断这种相互作用,从而减少或增加顶端腺病毒感染,因此,目前还没有针对柯萨奇病毒或腺病毒感染的特异性治疗方法。另一方面,增强受体顶端表达的能力对于腺病毒介导的肺部疾病基因治疗具有高度相关性。最后,这项工作将使研究生和本科生团队接触到病毒学和医学交叉领域的重要研究。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sidestream smoke exposure increases the susceptibility of airway epithelia to adenoviral infection.
侧流烟雾暴露会增加气道上皮对腺病毒感染的易感性。
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Sharma, Priyanka;Kolawole, Abimbola O;Core, Susan B;Kajon, Adriana E;Excoffon, Katherine J D A
- 通讯作者:Excoffon, Katherine J D A
Adenovirus transduction: More complicated than receptor expression.
腺病毒转导:比受体表达更复杂。
- DOI:
- 发表时间:2017-02
- 期刊:
- 影响因子:3.7
- 作者:Sharma, Priyanka;Martis, Prithy C;Excoffon, Katherine J D A
- 通讯作者:Excoffon, Katherine J D A
The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).
细胞支架蛋白 MAGI-1 的 PDZ3 结构域与柯萨奇病毒和腺病毒受体 (CAR) 相互作用。
- DOI:
- 发表时间:2015-04
- 期刊:
- 影响因子:0
- 作者:Yan, Ran;Sharma, Priyanka;Kolawole, Abimbola O;Martin, Sterling C T;Readler, James M;Kotha, Poornima L N;Hostetler, Heather A;Excoffon, Katherine J D A
- 通讯作者:Excoffon, Katherine J D A
Accessibility of the coxsackievirus and adenovirus receptor and its importance in adenovirus gene transduction efficiency.
柯萨奇病毒和腺病毒受体的可及性及其在腺病毒基因转导效率中的重要性。
- DOI:10.1099/vir.0.036269-0
- 发表时间:2024-09-13
- 期刊:
- 影响因子:0
- 作者:Priyanka Sharma;A. Kolawole;Sydney Marie Wiltshire;K. Frondorf;K. Excoffon
- 通讯作者:K. Excoffon
1. Alternative splicing of viral receptors: A review of the diverse morphologies and physiologies of adenoviral receptors.
1. 病毒受体的选择性剪接:腺病毒受体不同形态和生理学的综述。
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Excoffon, Katherine J D A;Bowers, Jonathan R;Sharma, Priyanka
- 通讯作者:Sharma, Priyanka
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Julie Excoffon其他文献
Katherine Julie Excoffon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Julie Excoffon', 18)}}的其他基金
Prevention of adenovirus pathogenesis through downregulation of the apical adenovirus receptor
通过下调顶端腺病毒受体预防腺病毒发病机制
- 批准号:
9445681 - 财政年份:2017
- 资助金额:
$ 44.4万 - 项目类别:
Molecular evolution of AAV vectors for anti-HIV gene therapy
用于抗 HIV 基因治疗的 AAV 载体的分子进化
- 批准号:
8294530 - 财政年份:2011
- 资助金额:
$ 44.4万 - 项目类别:
Molecular evolution of AAV vectors for anti-HIV gene therapy
用于抗 HIV 基因治疗的 AAV 载体的分子进化
- 批准号:
8210652 - 财政年份:2011
- 资助金额:
$ 44.4万 - 项目类别:
Isoform-Specific Regulation and Localization of the Coxsackie and Adenovirus Rece
柯萨奇病毒和腺病毒 Rece 的异构体特异性调控和定位
- 批准号:
7981132 - 财政年份:2010
- 资助金额:
$ 44.4万 - 项目类别:
相似国自然基金
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
TRIM35调控E1A病毒蛋白抑制腺病毒感染机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
L1-52/55K蛋白定点变异与3型、7型腺病毒感染毒力相关性和机制研究
- 批准号:81701995
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
纤毛杆影响嵌合型腺病毒感染T淋巴细胞效率的机制研究
- 批准号:31400149
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人3型腺病毒感染小动物模型的建立和体内应答特点研究
- 批准号:31370194
- 批准年份:2013
- 资助金额:77.0 万元
- 项目类别:面上项目
相似海外基金
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 44.4万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 44.4万 - 项目类别:
Role of miR-181a-5p in Adenovirus 14p1 induced Acute Lung Injury
miR-181a-5p在腺病毒14p1诱导的急性肺损伤中的作用
- 批准号:
10621862 - 财政年份:2022
- 资助金额:
$ 44.4万 - 项目类别:
Viral subversion of intercellular coupling during myocarditis
心肌炎期间细胞间耦合的病毒颠覆
- 批准号:
10656515 - 财政年份:2022
- 资助金额:
$ 44.4万 - 项目类别:
NK cell memory subsets and their impact on HIV disease progression and vaccination
NK 细胞记忆亚群及其对 HIV 疾病进展和疫苗接种的影响
- 批准号:
10673142 - 财政年份:2022
- 资助金额:
$ 44.4万 - 项目类别: